Kyoto University · Faculty of Medicine / Graduate School of Medicine · 教授

Research keywords乳癌・転移性乳癌・HR陽性HER2陰性乳癌・トリプルネガティブ乳癌・CDK4/6阻害薬・PARP阻害薬・内分泌療法

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer : KMBOG0610B2013 · 2013年04月01日
• Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3.1990 · European journal of cancer (Oxford, England : 1990),
• Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation.1990 · European journal of cancer (Oxford, England : 1990),
• A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes.1990 · European journal of cancer (Oxford, England : 1990),

• 乳癌治療における間質反応とエネルギー代謝に関する研究

• Official profile